OpenVSafe by OpenVAERS
Search V-safe

QHY-27716-14420

4 vaccinations 4 coded responses 12 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
330 / FL
Registered
2021-04-05
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-05
    Registered in v-safe
  2. 2021-04-05
    Dose 1 — Moderna
  3. 2021-04-05
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  5. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-04-14
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-04-26
    Dose 2 — Pfizer-BioNTech
  11. 2021-04-28
    Survey response — day 21, dose 1
    MedDRA: Chills, Dizziness, Migraine, Nausea, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nausea and migraine and dizziness and chills and fever
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-19
    Survey response — day 21, dose 2
    MedDRA: Migraine, Nausea — Feeling: Fair
    Free text: Migraines and nausea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-06-07
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  14. 2021-10-31
    Dose 3 — Moderna
  15. 2022-05-02
    Survey response — 6 months, dose 3
    MedDRA: Abortion spontaneous — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-05-02
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-05-17
    Dose 4 — Pfizer-BioNTech

Vaccinations

DoseDateManufacturerCo-administered
12021-04-05Moderna
22021-04-26Pfizer-BioNTech
32021-10-31Moderna No
42022-05-17Pfizer-BioNTech No

Free text

Release 8 — day 21, dose 1

2021-04-28

Symptoms: Nausea and migraine and dizziness and chills and fever

Release 8 — day 21, dose 2

2021-05-19

Symptoms: Migraines and nausea

Release 11 — 12 months, dose 2

2022-05-02

Symptoms: Miscarriage

Release 11 — 6 months, dose 3

2022-05-02

Symptoms: Miscarriage

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDChills ✓ ✓ ✓
SDDizziness ✓ ✓ ✓
SDMigraine ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release